There is mounting evidence for the increasing need for a culturally representative nursing workforce in the United States, especially as our population continues to become more diverse. Between 2000 and 2020, the number of non-white Americans is expected to rise by 50%. Presently there are 35.5 million Hispanics in the United States and many more that are undocumented; it is estimated that by the year 2050, 25% of the U.S. population will be Hispanic. The Asian population has increased by 48% since 1991.^^ To better serve the diverse U.S. population, research nurses should mirror that population. According to the Sullivan Commission, almost 25% of the U.S. population is Hispanic American, AA, and American Indian. However, only 9% of the nursing workforce falls within these ethnic or racial groups. Furthermore, the latest evidence shows that concordance of patient and physician race, ethnicity, and language influences processes of health outcome and participation in research.^'^^'^^ Informal studies from our MB-CCOP have revealed that community-based and hospital-based oncologists are willing to conduct clinical trials; however their main request is for minority CRAs who can support the recruitment and follow up of minority patients and can work effectively with physicians and navigators. In addition, they recommend hiring CRA's who can deliver culturally appropriate interventions and can build trust with the community. To that end, Dillard University, where most minority nurses in Louisiana are trained, is partnering with LSUHSC to develop a program for the certification of CRAs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD004817-02
Application #
8232951
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
2
Fiscal Year
2011
Total Cost
$67,824
Indirect Cost
Name
Dillard University
Department
Type
DUNS #
062665468
City
New Orleans
State
LA
Country
United States
Zip Code
70122
Sanabria-Salas, María Carolina; Hernández-Suárez, Gustavo; Umaña-Pérez, Adriana et al. (2017) IL1B-CGTC haplotype is associated with colorectal cancer in admixed individuals with increased African ancestry. Sci Rep 7:41920
Loupe, Jacob M; Miller, Patrick J; Crabtree, Judy S et al. (2017) Acquisition of an oncogenic fusion protein is sufficient to globally alter the landscape of miRNA expression to inhibit myogenic differentiation. Oncotarget 8:87054-87072
Rawlik, Konrad; Rowlatt, Amy; Sanabria-Salas, María Carolina et al. (2017) Evidence of epigenetic admixture in the Colombian population. Hum Mol Genet 26:501-508
Garay, Jone; Piazuelo, M Blanca; Lopez-Carrillo, Lizbeth et al. (2017) Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies. Oncotarget 8:47076-47089
Serrano-Gomez, Silvia Juliana; Sanabria-Salas, Maria Carolina; Hernández-Suarez, Gustavo et al. (2016) High prevalence of luminal B breast cancer intrinsic subtype in Colombian women. Carcinogenesis 37:669-676
Joseph, Ann Mary; Srivastava, Ratika; Zabaleta, Jovanny et al. (2016) Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects. Cancer Immunol Res 4:708-16
Dai, Lu; Bai, Lihua; Lin, Zhen et al. (2016) Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus. Oncotarget 7:47052-47060
Maxi, John K; Dean, Matt; Zabaleta, Jovanny et al. (2016) Chronic Binge Alcohol Administration Dysregulates Hippocampal Genes Involved in Immunity and Neurogenesis in Simian Immunodeficiency Virus-Infected Macaques. Biomolecules 6:
Loupe, J M; Miller, P J; Bonner, B P et al. (2016) Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion. Oncogenesis 5:e246
Loupe, Jacob M; Miller, Patrick J; Bonner, Benjamin P et al. (2016) Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects. Oncotarget 7:62814-62835

Showing the most recent 10 out of 23 publications